Free Trial

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Glencore stock logo

1. Glencore OTCMKTS:GLNCY

$7.79 +0.18 (+2.37%)
As of 06/4/2025 04:00 PM Eastern

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about Glencore

Market Capitalization
$45.58 billion
Consensus Rating
Strong Buy
Volume
716,170 shares
Average Volume
1.16 million shares
Today's Range
$7.76
$7.83
50-Day Range
$5.84
$7.79
Birchcliff Energy stock logo

2. Birchcliff Energy OTCMKTS:BIREF

$4.93 -0.03 (-0.51%)
As of 06/4/2025 03:45 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.34 billion
P/E Ratio
35.18
Consensus Rating
Strong Buy
Volume
15,822 shares
Average Volume
85,236 shares
Today's Range
$4.89
$4.97
NexGen Energy stock logo

3. NexGen Energy NYSE:NXE

$6.41 +0.04 (+0.63%)
As of 06/4/2025 03:58 PM Eastern

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$3.65 billion
P/E Ratio
42.74
Consensus Rating
Strong Buy
Volume
9.29 million shares
Average Volume
7.18 million shares
Today's Range
$6.27
$6.45
Sky Harbour Group stock logo

4. Sky Harbour Group NYSEAMERICAN:SKYH

$9.88 +0.04 (+0.41%)
As of 06/4/2025 04:10 PM Eastern

Sky Harbour Group Corporation operates as an aviation infrastructure development company in the United States. It develops, leases, and manages general aviation hangars for business aircraft. More about Sky Harbour Group

Market Capitalization
$747.03 million
P/E Ratio
-4.77
Consensus Rating
Buy
Consensus Price Target
$18.50 (+87.2% Upside)
Volume
266,064 shares
Average Volume
106,077 shares
OS Therapies stock logo

5. OS Therapies NYSE:OSTX

$1.66 +0.07 (+4.40%)
As of 06/4/2025 04:00 PM Eastern

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$46.64 million
P/E Ratio
-1.93
Consensus Rating
Buy
Consensus Price Target
$18.00 (+984.3% Upside)
Volume
245,721 shares
Average Volume
463,968 shares
Bitcoin Depot stock logo

6. Bitcoin Depot NASDAQ:BTM

$4.49 -0.11 (-2.39%)
As of 06/4/2025 04:00 PM Eastern

Bitcoin Depot Inc owns and operates a network of cryptocurrency kiosks in North America. Its customers can buy and sell bitcoin, litecoin, and ethereum cryptocurrencies using the BTM kiosk network and other services. More about Bitcoin Depot

Market Capitalization
$288.76 million
P/E Ratio
-4.83
Consensus Rating
Buy
Consensus Price Target
$4.83 (+7.6% Upside)
Volume
1.42 million shares
Average Volume
596,565 shares
zSpace stock logo

7. zSpace NASDAQ:ZSPC

$4.84 +0.48 (+11.01%)
As of 06/4/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$110.75 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+209.9% Upside)
Volume
43,703 shares
Average Volume
66,217 shares
Today's Range
$4.15
$4.92
Cardiol Therapeutics stock logo

8. Cardiol Therapeutics NASDAQ:CRDL

$1.45 +0.14 (+10.69%)
As of 06/4/2025 04:00 PM Eastern

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$108.22 million
P/E Ratio
-3.72
Consensus Rating
Buy
Consensus Price Target
$8.67 (+497.7% Upside)
Volume
506,742 shares
Average Volume
355,774 shares
Denison Mines stock logo

9. Denison Mines NYSEAMERICAN:DNN

$1.65 -0.04 (-2.37%)
As of 06/4/2025 04:10 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.48 billion
P/E Ratio
-165.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+81.8% Upside)
Volume
141.70 million shares
Average Volume
37.77 million shares
Coeur Mining stock logo

10. Coeur Mining NYSE:CDE

$8.98 +0.18 (+2.05%)
As of 06/4/2025 03:58 PM Eastern

Coeur Mining, Inc explores for precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. More about Coeur Mining

Market Capitalization
$5.74 billion
P/E Ratio
74.84
Consensus Rating
Buy
Consensus Price Target
$8.10 (-9.8% Downside)
Volume
14.92 million shares
Average Volume
12.58 million shares
OnKure Therapeutics stock logo

11. OnKure Therapeutics NASDAQ:OKUR

$2.89 +0.20 (+7.43%)
As of 06/4/2025 04:00 PM Eastern

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$39.04 million
P/E Ratio
-0.24
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,018.8% Upside)
Volume
158,894 shares
Average Volume
111,992 shares
Bioceres Crop Solutions stock logo

12. Bioceres Crop Solutions NASDAQ:BIOX

$4.92 -0.08 (-1.60%)
As of 06/4/2025 04:00 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$308.54 million
P/E Ratio
246.12
Consensus Rating
Buy
Consensus Price Target
$8.63 (+75.3% Upside)
Volume
75,551 shares
Average Volume
174,487 shares
VNET Group stock logo

13. VNET Group NASDAQ:VNET

$5.82 +0.28 (+5.05%)
As of 06/4/2025 04:00 PM Eastern

VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET Group

Market Capitalization
$1.57 billion
P/E Ratio
-2.62
Consensus Rating
Buy
Consensus Price Target
$9.30 (+59.8% Upside)
Volume
4.08 million shares
Average Volume
4.61 million shares
Trevi Therapeutics stock logo

14. Trevi Therapeutics NASDAQ:TRVI

$6.58 +0.63 (+10.59%)
As of 06/4/2025 04:00 PM Eastern

Trevi Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. More about Trevi Therapeutics

Market Capitalization
$657.30 million
P/E Ratio
-14.95
Consensus Rating
Buy
Consensus Price Target
$18.63 (+183.1% Upside)
Volume
9.06 million shares
Average Volume
1.30 million shares
GeoVax Labs stock logo

15. GeoVax Labs NASDAQ:GOVX

$1.12 +0.07 (+6.67%)
As of 06/4/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$17.02 million
P/E Ratio
-0.31
Consensus Rating
Buy
Consensus Price Target
$11.10 (+891.1% Upside)
Volume
291,794 shares
Average Volume
514,993 shares
Quince Therapeutics stock logo

16. Quince Therapeutics NASDAQ:QNCX

$1.09 +0.04 (+3.81%)
As of 06/4/2025 04:00 PM Eastern

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$49.56 million
P/E Ratio
-0.88
Consensus Rating
Buy
Consensus Price Target
$8.00 (+633.9% Upside)
Volume
85,493 shares
Average Volume
287,195 shares
Reviva Pharmaceuticals stock logo

17. Reviva Pharmaceuticals NASDAQ:RVPH

$0.81 0.00 (-0.13%)
As of 06/4/2025 04:00 PM Eastern

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$38.12 million
P/E Ratio
-0.73
Consensus Rating
Buy
Consensus Price Target
$9.00 (+1,005.0% Upside)
Volume
392,352 shares
Average Volume
1.14 million shares
Uranium Energy stock logo

18. Uranium Energy NYSEAMERICAN:UEC

$6.15 -0.21 (-3.30%)
As of 06/4/2025 04:10 PM Eastern

Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. More about Uranium Energy

Market Capitalization
$2.60 billion
P/E Ratio
-51.25
Consensus Rating
Buy
Consensus Price Target
$10.13 (+64.6% Upside)
Volume
11.50 million shares
Average Volume
8.53 million shares
Mind Medicine (MindMed) stock logo

19. Mind Medicine (MindMed) NASDAQ:MNMD

$7.65 -0.04 (-0.52%)
As of 06/4/2025 04:00 PM Eastern

Mind Medicine (MindMed) Inc, a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. More about Mind Medicine (MindMed)

Market Capitalization
$581.00 million
P/E Ratio
-3.38
Consensus Rating
Buy
Consensus Price Target
$25.50 (+233.3% Upside)
Volume
910,557 shares
Average Volume
1.38 million shares
MannKind stock logo

20. MannKind NASDAQ:MNKD

$4.35 -0.07 (-1.58%)
As of 06/4/2025 04:00 PM Eastern

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.32 billion
P/E Ratio
62.14
Consensus Rating
Buy
Consensus Price Target
$10.00 (+129.9% Upside)
Volume
2.24 million shares
Average Volume
2.37 million shares
Full House Resorts stock logo

21. Full House Resorts NASDAQ:FLL

$3.14 -0.04 (-1.26%)
As of 06/4/2025 04:00 PM Eastern

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$112.97 million
P/E Ratio
-2.66
Consensus Rating
Buy
Consensus Price Target
$5.67 (+80.5% Upside)
Volume
148,125 shares
Average Volume
143,013 shares
Aura Biosciences stock logo

22. Aura Biosciences NASDAQ:AURA

$6.14 -0.19 (-3.00%)
As of 06/4/2025 04:00 PM Eastern

Aura Biosciences, Inc, a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. More about Aura Biosciences

Market Capitalization
$308.65 million
P/E Ratio
-3.55
Consensus Rating
Buy
Consensus Price Target
$22.00 (+258.3% Upside)
Volume
171,971 shares
Average Volume
207,166 shares
TriSalus Life Sciences stock logo

23. TriSalus Life Sciences NASDAQ:TLSI

$5.16 -0.03 (-0.58%)
As of 06/4/2025 04:00 PM Eastern

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$195.25 million
P/E Ratio
-2.07
Consensus Rating
Buy
Consensus Price Target
$10.75 (+108.3% Upside)
Volume
20,166 shares
Average Volume
42,204 shares
Astria Therapeutics stock logo

24. Astria Therapeutics NASDAQ:ATXS

$5.28 +0.32 (+6.45%)
As of 06/4/2025 04:00 PM Eastern

Astria Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. More about Astria Therapeutics

Market Capitalization
$297.97 million
P/E Ratio
-2.53
Consensus Rating
Buy
Consensus Price Target
$30.00 (+468.2% Upside)
Volume
293,144 shares
Average Volume
371,879 shares
Immunic stock logo

25. Immunic NASDAQ:IMUX

$0.78 +0.04 (+6.11%)
As of 06/4/2025 04:00 PM Eastern

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$74.26 million
P/E Ratio
-0.63
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,396.8% Upside)
Volume
1.11 million shares
Average Volume
790,325 shares